Biogen and Elan voluntarily withdraw multiple sclerosis drug; shares plunge

BOSTON (AP) - The makers of Tysabri, a new drug used to treat multiple sclerosis, are voluntarily suspending sales of the drug after one patient died and another developed a serious disease of the central nervous system.

Stocks of both Biogen Idec Inc. and Elan Corp....More